|
|
 |
BARHEMSYS Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
FD&C YELLOW NO. 5 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
FLONASE SENSIMIST ALLERGY RELIEF Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ACETYLTRIBUTYL CITRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ANHYDROUS DIBASIC CALCIUM PHOSPHATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|